Commonwealth Equity Services’s iShares Genomics Immunology and Healthcare ETF IDNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $640K | Buy |
31,202
+490
| +2% | +$10.1K | ﹤0.01% | 2956 |
|
|
2025
Q1 | $629K | Buy |
30,712
+1,048
| +4% | +$21.5K | ﹤0.01% | 2846 |
|
|
2024
Q4 | $671K | Sell |
29,664
-5,225
| -15% | -$118K | ﹤0.01% | 2735 |
|
|
2024
Q3 | $859K | Sell |
34,889
-16,105
| -32% | -$397K | ﹤0.01% | 2466 |
|
|
2024
Q2 | $1.18M | Sell |
50,994
-59
| -0.1% | -$1.36K | ﹤0.01% | 2152 |
|
|
2024
Q1 | $1.23M | Buy |
51,053
+563
| +1% | +$13.6K | ﹤0.01% | 2102 |
|
|
2023
Q4 | $1.16M | Sell |
50,490
-1,607
| -3% | -$37K | ﹤0.01% | 2069 |
|
|
2023
Q3 | $1.06M | Buy |
52,097
+1,840
| +4% | +$37.4K | ﹤0.01% | 2033 |
|
|
2023
Q2 | $1.17M | Buy |
50,257
+2,417
| +5% | +$56.5K | ﹤0.01% | 1980 |
|
|
2023
Q1 | $1.11K | Sell |
47,840
-30,957
| -39% | -$720 | ﹤0.01% | 1971 |
|
|
2022
Q4 | $1.98M | Sell |
78,797
-23,370
| -23% | -$588K | ﹤0.01% | 1505 |
|
|
2022
Q3 | $2.7M | Buy |
102,167
+56,410
| +123% | +$1.49M | 0.01% | 1235 |
|
|
2022
Q2 | $1.32M | Buy |
45,757
+2,805
| +7% | +$81K | ﹤0.01% | 1684 |
|
|
2022
Q1 | $1.48M | Buy |
42,952
+20,868
| +94% | +$719K | ﹤0.01% | 1699 |
|
|
2021
Q4 | $967K | Buy |
22,084
+3,340
| +18% | +$146K | ﹤0.01% | 2014 |
|
|
2021
Q3 | $950K | Buy |
18,744
+1,061
| +6% | +$53.8K | ﹤0.01% | 1960 |
|
|
2021
Q2 | $920K | Buy |
17,683
+3,390
| +24% | +$176K | ﹤0.01% | 1974 |
|
|
2021
Q1 | $653K | Buy |
14,293
+4,002
| +39% | +$183K | ﹤0.01% | 2118 |
|
|
2020
Q4 | $472K | Buy |
10,291
+2,009
| +24% | +$92.1K | ﹤0.01% | 2187 |
|
|
2020
Q3 | $322K | Buy |
+8,282
| New | +$322K | ﹤0.01% | 2300 |
|